FigureĀ 1.
Outcomes of haploidentical vs MSD-PTCy HCT. Kaplan-Meier probability of OS, and cumulative incidence of relapse and NRM comparing haploidentical donor (Haplo-PTCy, red) vs HLA-MSD (MSD-PTCy, green).

Outcomes of haploidentical vs MSD-PTCy HCT. Kaplan-Meier probability of OS, and cumulative incidence of relapse and NRM comparing haploidentical donor (Haplo-PTCy, red) vs HLA-MSD (MSD-PTCy, green).

Close Modal

or Create an Account

Close Modal
Close Modal